PMID: 11532579Sep 5, 2001Paper

Preparation and characterisation of a range of diclofenac salts

International Journal of Pharmaceutics
K M O'Connor, O I Corrigan


Physicochemical properties of diclofenac salts prepared using eight different counterions and including five novel salts, obtained with the bases 2-amino-2-methyl-1,3-propanediol, 2-amino-2-methylpropanol, tert-butylamine, benzylamine and deanol, were compared. Four of the bases used to prepare these salts were related in their chemical structure, differing only in the number of hydroxy groups. Characterisation techniques included X-ray diffraction, differential scanning calorimetry, thermogravimetric analysis, thermomicroscopy, Karl Fischer titration, FT-IR spectroscopy and elemental analysis. In the case of salts prepared from 2-amino-2-methylpropanol and benzylamine, two polymorphic forms of each salt were identified. For the 2-amino-2-methyl-1,3-propanediol salt, a pseudopolymorphic form was identified. The aqueous solubilities of the salts studied ranged from 3.95 mM (tris(hydroxymethyl)aminomethane salt) to 446 mM (deanol salt), corresponding to a 113-fold difference in solubility. The solubility of diclofenac deanol was higher than the solubilities for diclofenac salts reported earlier. Correlation was found between the inverse of the salt melting point and the logarithm of salt solubility. A log-log relationship was obs...Continue Reading


Sep 1, 1978·Journal of Pharmaceutical Sciences·Z T Chowhan
Feb 1, 1978·Journal of Pharmaceutical Sciences·C A HirschJ L Brannon
Jan 1, 1977·Journal of Pharmaceutical Sciences·S M BergeD C Monkhouse
Apr 1, 1975·Journal of Pharmaceutical Sciences·K G Nelson, A C Shah
Sep 1, 1975·Journal of Pharmaceutical Sciences·A C Shah, K G Nelson
Jun 1, 1989·Journal of Pharmaceutical Sciences·J T Rubino
Apr 16, 1987·Biochimica Et Biophysica Acta·V Dhanaraj, M Vijayan
Aug 1, 1985·Journal of Pharmaceutical Sciences·B D Anderson, R A Conradi
Apr 1, 1974·Journal of Pharmaceutical Sciences·G L FlynnT J Roseman
Mar 1, 1969·Journal of Pharmaceutical Sciences·P H JonesA H Chun
Jan 1, 1981·Journal of Pharmaceutical Sciences·K G MooneyV J Stella
Nov 15, 1994·Acta Crystallographica. Section C, Crystal Structure Communications·C Castellari, P Sabatino
Jun 17, 1999·International Journal of Pharmaceutics·A FiniM A Holgado
Mar 4, 2000·Journal of Pharmaceutical and Biomedical Analysis·M E PalomoP Frutos
Jan 1, 1965·Journal of Pharmaceutical Sciences·W I HIGUCHIW E HAMLIN

❮ Previous
Next ❯


Apr 15, 2004·International Journal of Pharmaceutics·Vimon Tantishaiyakul
May 10, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Margit HornofAndreas Bernkop-Schnürch
Apr 6, 2007·Chemical & Pharmaceutical Bulletin·Jahanbakhsh Ghasemi, Saadi Saaidpour
Sep 13, 2002·Journal of Pharmaceutical Sciences·Karen M O'Connor, Owen I Corrigan
Oct 4, 2005·Journal of Pharmaceutical Sciences·Adamo FiniJosefa Alvarez-Fuentes
Jan 12, 2012·Journal of Pharmaceutical Sciences·Adamo FiniRita Morigi
Jun 6, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ekarat JantratidJennifer B Dressman
Dec 7, 2007·Drug Discovery Today·Lokesh KumarArvind K Bansal
May 4, 2007·International Journal of Pharmaceutics·Henry R CostantinoSteven C Quay
Jun 23, 2005·The Journal of Pharmacy and Pharmacology·Majella E LaneOwen I Corrigan
Mar 3, 2012·Drug Development and Industrial Pharmacy·Benjamin M CollmanAnthony C Blackburn
Nov 29, 2011·Drug Development and Industrial Pharmacy·S E DavidB R Conway
Jun 21, 2013·Drug Development and Industrial Pharmacy·Vineet Kumar RaiShubhini A Saraf
Sep 24, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Atsushi KambayashiJennifer Dressman
Nov 3, 2010·The Journal of Pharmacy and Pharmacology·Sarah E DavidBarbara R Conway
Jun 20, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Sontaya LimmatvapiratManee Luangtana-Anan
Nov 3, 2009·Drug Development and Industrial Pharmacy·Grzegorz Garbacz, Werner Weitschies
Mar 15, 2018·Physical Chemistry Chemical Physics : PCCP·Mariana KozlowskaAnna Kaczmarek-Kedziera
Feb 7, 2013·Pharmacological Reviews·Hywel D WilliamsChristopher J H Porter

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.